Zimmer Biomet’s ZBH strategic priorities, new product launches and focus on international expansion bolster our confidence in this stock. Yet, the difficult macroeconomic situation and FX issues are...
Abbott ABT recently announced results from its REFLECT real-world studies, conducted using data from the comprehensive Swedish National Diabetes Register. The findings revealed that the company’s FreeStyle...
Medtronic plc MDT is scheduled to report fourth-quarter and full-year fiscal 2025 results on May 21, before the opening bell.In the last reported quarter, the company’s adjusted earnings of $1.39 exceeded...
Despite facing a challenging industry-wide investment climate driven by tariffs, Abbott ABT has managed to achieve an 18.8% gain so far in 2025, outperforming the industry, its benchmark, and the company’s...
For Immediate ReleaseChicago, IL – May 6, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...
After two strong years, 2025 was expected to mark another high-growth chapter for the MedTech industry, particularly in health technology. Instead, recent first-quarter results show a different story....
/Boston%20Scientific%20Corp_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Boston Scientific has outpaced the broader market over the past year and analysts are highly upbeat about its future prospects.
For Immediate ReleaseChicago, IL – May 2, 2025 – Today, Zacks Investment Ideas feature highlights Boston Scientific BSX, Meta Platforms META and Microsoft MSFT.These 3 Stocks Soared Following Quarterly...
The 2025 Q1 earnings cycle is in full swing, with many companies on the docket to reveal quarterly results in the coming weeks.Guidance is a key factor in this cycle, more so than we’ve seen in recent...